

TRADING UPDATES: Yellow Cake fundraises; Mercia Asset invests


(Sharecast News) - Cell-based therapeutic specialist ReNeuron has entered a collaboration agreement with University College London (UCL), it announced...


(Sharecast News) - Reneuron Group revealed on Thursday that non-executive director Barbara Staehelin had acquired 43,000 ordinary shares in the AIM-li...


DIRECTOR DEALINGS: Inspiration Healthcare exec sells 135,000 shares


TRADING UPDATES: Mind Gym revenue recovers; Dispersion buys Accru


(Sharecast News) - Cell-based therapeutics developer ReNeuron Group said on Monday that the first UK subject had been treated at the Oxford Eye Hospit...


(Sharecast News) - Exosome therapeutics developer ReNeuron announced positive data on Monday that it said provided "clear preclinical proof-of-concept...


IN BRIEF: ReNeuron gets positive results from exosome drug data